baber/WOPTO huggingface dataset:
Patent NZ-548713-A (NZ)
Title: Ice cream and ice cream formulations containing maltitol
Inventor: DEIS RONALD C
IPC: A23L27/30
Filed: 2005-01-12
Abstract: Disclosed is an ice cream formulation comprising: a) fat in an amount of from 6 to 15% by weight, based on the total weight of the ice cream formulation; b) non-fat milk solids in an amount of from 6 to 12% by weight, based on the total weight of the ice cream formulation; and c) malitol in an amount from 30 to 45% by weight on a dry solids basis.
Patent NZ-549290-A (NZ)
Title: Retrieval mechanism for retrieving a netting material from a surface
Inventor: DAVEY ALAN
Filed: 2006-08-17
Abstract: A retrieval mechanism including a drive mechanism (2), linkages (3), a collector (4), a frame (5), handles (6) and a clutch system (7). The drive mechanism is formed from ground wheels (8) and ground wheel pulley (10) mounted to the frame. Linkages are formed from belts (12), collector pulleys (14) and stub axles (16), the collector pulley being mounted on a frame that is free to rotate, collector pulley having a stub axle extending towards the inward plane of the frame. The stub axle receives and engages the axle of the collector, the axle shaped so as to slide over the connector. A clutch is formed from an engagement means (29), connection means (30) and levers (20). A handle(21) is attached to the frame so that is can be easily engaged by the user
Patent NZ-551202-A (NZ)
Title: A detector for detecting molecules conveyed through a gaseous medium
Inventor: WENZHI WU
IPC: G01N27/12
Filed: 2005-04-21
Abstract: A method for detecting molecules conveyed through a gaseous medium comprises the steps of exposing a detector to molecules emitted from at least one of a sewage plant, a rubbish processing plant and a meat processing plant, and measuring a change in an electrical property of the detector and thereby detecting the molecules. The detector is sensitive for organic molecules and for molecules that contain sulphur.
Patent NZ-552265-A (NZ)
Title: Anti-rhesus D recombinant polyclonal antibody and methods of manufacture
Inventor: RASMUSSEN SOREN KOFOED
Filed: 2005-07-18
Abstract: Disclosed is an anti-RhD recombinant polyclonal antibody (anti-RhD rpAb) consisting of the constant regions IgG1 and/or IgG3, and method for producing such. The method comprises generating a collection of cells transfected with a library of anti-RhD antibody expression vectors, wherein each vector contains a nucleic acid segment that encodes a distinct member of the anti-RhD recombinant polyclonal antibody composition. The cells comprising an integrated copy of the anti-RhD antibody-encoding nucleic acid segment from the said library are then selected. The anti-RhD rpAbs are considered a superior replacement of prior plasma-derived prophylactic and therapeutic immonoglobulin products.
Patent NZ-554272-A (NZ)
Title: Method and apparatus for delivering an anesthetic agent to the abdomen
Inventor: OTT DOUGLAS E
IPC: A61M37/00
Filed: 2004-10-07
Abstract: A method of preparing an insufflation gas and at least one anesthetic, the method comprising a) supplying a gas stream from an insufflator 915 which supplies pressure and volumetrically controlled gas, b) injecting the at least one anesthetic into the gas stream upstream of any device 120 which heats or humidifies the gas stream to produce an anesthetic gas stream, and c) delivering the anesthetic gas stream.
Patent NZ-561128-A (NZ)
Title: Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
Inventor: DUGGER HARRY A
Filed: 2003-08-27
Abstract: Disclosed is a propellant free buccal spray composition for transmucosal administration of a pharmacologically active compound comprising an active compound in an amount between 0.005 and 55 percent by weight of the total composition selected from the group consisting of anti-spasmodics, agents for treating urinary incontinence, anti-diarrheal agents selected from the group consisting of palnosetron, tropisetron, attapulgite, atropine, bismuth, diphenoxylate, loperamide, and mixtures thereof, agents for treating nausea and/or vomiting selected from the group consisting of alosetron, dolasetron, granisetron, meclizine, metoclopramide, palnosetron, prochloperazine, promethazine, trimethobenzamide, tropisetron, and mixtures thereof, smooth muscle contractile agents, anti-secretory agents, enzymes, anti- diuretics selected from the group consisting of benzthiazide, bendroflumethazide, bumetanide, chlorthalidone, chIomthiazide, ethacrynic acid, furosemide, hydrochlorothiazide, hydroflumethiazide, methyclothiazlde, polythiazide, quinethazone, spironolactone, triamterene, torsemide, trichlomethiazide, and mixtures thereof, anti-ulcerants selected from the group consisting of ranitidine, misoprostol, sucralfate, pantoprazole, lansoprazole, orneprazole, and mixtures thereof, bile acid replacement and/or gallstone solubilizing drugs, and mixtures thereof; and a non-polar solvent in an amount between 30 and 99 percent by weight of the total composition.
Patent NZ-563452-A (NZ)
Title: Treatment of TNFalpha related disorders
Inventor: BANERJEE SUBHASHIS
IPC: A61K/
Filed: 2003-07-18
Abstract: Provided is the use of a neutralizing, high affinity human anti-TNF alpha antibody, or antigen binding portion thereof, in the preparation of a medicament for treating psoriasis, wherein the medicament is adapted for biweekly administration and comprises a dosage of 10-150 mg of the neutralizing, high affinity human anti-TNF alpha antibody, or antigen binding portion thereof. Further provided are specific variants of the antibody and dosage regimens for such use.
Patent NZ-568702-A (NZ)
Title: Electric cable comprising a foamed polyolefine insulation and manufacturing process thereof
Inventor: FRIGERIO MARCO
IPC: C08J9/10
Filed: 2005-12-22
Abstract: Disclosed is a process for manufacturing an electric cable comprising at least one core comprising a conductor and an insulating coating surrounding said conductor, said process comprising the steps of providing a polyolefin material, a silane-based cross-linking system and a foaming system comprising at least one exothermic foaming agent in an amount of from 0.1 percent to 0.5 percent by weight with respect to the total weight of the polyolefin material; forming a blend with the polyolefin material, the silane-based cross-linking system and the foaming system and extruding the blend on the conductor to form the insulating coating.Also disclosed is an electrical cable comprising an insulating coating of a silane-based cross-linking system with polyolefin material and a method of improving ageing stability comprising said coating.
Patent NZ-580973-A (NZ)
Title: Pharmaceutical formulations containing lipoic acid derivatives
Inventor: SHORR ROBERT G
IPC: A01N43/26
Filed: 2008-04-17
Abstract: Disclosed herein is a pharmaceutical formulation comprising: (a) at least one lipoic acid derivative of Formula I¸ Formula II, or a salt thereof wherein the substituents are as defined in the specification; (b) at least one ion pairing agent that is either: (i) a tertiary amine, diethanolamine, monoethanolamine, mefenamic acid, tromethamine, or a combination thereof; (ii) a polymer-conjugated ion pairing agent; or (iii) ammonia, L-arginine, benethamine, benzathine, betaine, calcium hydroxide, choline, deanol, diethylamine, 2-(diethylamino)-ethanol, ethylenediamine, N-methyl-glucamine, hydrabamine, 1H-imidazole, lysine, magnesium hydroxide, 4-(2-hydroxyethyl)-morpholine, piperazine, potassium hydroxide, 1-(2-hydroxyethyl)-pyrrolidine, sodium hydroxide, or zinc hydroxide; and (c) a pharmaceutically acceptable diluent; wherein the lipoic acid derivative and the ion pairing agent form an ion pair. Such compositions are useful in the treatment/prevention of diseases characterized by disease cells that are sensitive to lipoic acid derivatives, such as carcinoma, sarcoma, myeloma, lymphoma, leukemia and mixed types thereof.
Patent NZ-585453-A (NZ)
Title: A composition comprising a perhydrolase enzyme an a removal enzyme mixture
Inventor: BARNETT CHRISTOPHER
IPC: A01N63/50
Filed: 2008-12-16
Abstract: Disclosed is a method for removing biofilm from a surface, said method comprising applying a perhydrolase enzyme and a removal enzyme mixture to said biofilm for a time sufficient to reduce said biofilm by at least 25%, wherein said enzyme mixture is selected from protease, glucanase, and esterase; protease, glucanase, esterase, and mannanase; protease, glucanase, phospholipase, and mannanase; three proteases, glucanase, phospholipase, and mannanase; three proteases, glucanase, and mannanase; two proteases, cellulase, glucanases, phospholipase, and mannanase; protease, glucanase, and mannanase; protease, cellulase, phospholipase, and esterase; two proteases, glucanase, phospholipase, and esterase; two proteases, glucanase, phospholipase, and mannanase; three proteases, cellulase, phospholipase, and glucanase; three proteases, cellulase, phospholipase, and mannanase; three proteases, glucanase, phospholipase and esterase; protease, cellulase, glucanase, phospholipase, and esterase; at least two amylases and glucanase; at least three amylases; and at least two amylases, glucanase, and protease.
Patent NZ-590262-A (NZ)
Title: Method for preparing a patient for a medical treatment
Inventor: BUCOLO SALVATORE
IPC: G16H70/20
Filed: 2009-07-14
Abstract: 590262 Disclosed is a method for using an electronic device (100) having a display (112) to prepare a patient for a medical treatment. A world is represented on the display (112) and one or more medical objects related to the medical treatment are placed in the world. An input is received from the patient to select the medical objects and feedback is provided to the patient to indicate that the medical objects have been selected. One or more obscuring objects in the world are represented and the medical objects are obscured by one or more of the obscuring objects.
Patent NZ-594485-A (NZ)
Title: Sglt-2 inhibitor for reducing body fat, or preventing an increase in body fat
Inventor: EICKELMANN PETER
IPC: A61K31/7034
Filed: 2010-02-11
Abstract: 594485 Disclosed herein is the use of SGLT2 inhibitor 1-chloro-4-(?-D-glucopyranos-1-yl)-2-[4-((S)-tetrahydrofuran-3-yloxy)-benzyl]-benzene for the manufacture of a medicament for reducing body fat or preventing an increase in body fat, or facilitating a reduction in body fat, in a patient in need thereof. Specifically wherein the patient is an individual diagnosed of one or more of the conditions selected from the group consisting of overweight, obesity, visceral obesity and abdominal obesity.
Patent NZ-596264-A (NZ)
Title: Power monitoring system
Inventor: GELONESE GUISEPPE ANTONIO
IPC: H02J3/14
Filed: 2010-06-03
Abstract: A system for monitoring power consumption of a plurality of electrical devices is disclosed. The system includes means for communicating with a centralised energy saving device, remote to the plurality of electrical devices, of the type permitting energisation of a plurality of electrical devices from a single mains supply electrical outlet; monitoring means and output means. The centralised energy saving device has a plurality of controlled electrical outlets and a single electrical input adapted to connect to a mains supply electrical output; and switch means adapted to connect electrical supply from the mains supply electrical outlet to each of the controlled electrical outlets in response to a sensed state of at least one of the plurality of electrical devices. The monitoring means monitors power consumption of the controlled electrical outlets and the output means outputs data relating to the monitored power consumption.
Patent NZ-598856-A (NZ)
Title: Preventative agent and/or therapeutic agent and/or exacerbation-suppressing agent for human knee osteoarthritis
Inventor: ISHIZUYA TOSHINORI
IPC: A61K38/22
Filed: 2010-11-05
Abstract: Disclosed is a drug that is useful for the prevention and/or therapy and/or exacerbation-suppression of human knee osteoarthritis. The drug is characterized by containing parathyroid hormone (PTH) or a PTH derivative as an active ingredient for the prevention and/or therapy and/or exacerbation-suppression of human knee osteoarthritis.
Patent NZ-599061-A (NZ)
Title: Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
Inventor: ROWE JONATHAN
IPC: A61K31/215
Filed: 2010-09-23
Abstract: NZ 599061 The disclosure relates to a pharmaceutical composition for the treatment of cardiovascular disease selected from hypertriglyceridemia, hypercholesterolemia, mixed dyslipidemia, coronary heart disease, vascular disease, stroke, atherosclerosis, arrhythmia, hypertension, and myocardial infarction, wherein the composition comprises: (a) a hydroxy-derivative of a statin or pharmaceutically acceptable salt thereof, wherein the hydroxy-derivative of a statin or pharmaceutically acceptable salt thereof is selected from o-hydroxy atorvastatin, p-hydroxy atorvastatin, p-hydroxy atorvastatin calcium, p-hydroxy atorvastatin disodium, o-hydroxy atorvastatin calcium, o-hydroxy atorvastatin lactone, ohydroxy atorvastatin-d5 calcium, o-hydroxy atorvastatin-d5 disodium, o-hydroxy atorvastatin-d5 lactone, 2-hydroxy atorvastatin bisodium, p-hydroxy atorvastatin lactone, p-hydroxy atorvastatin-d5 calcium, p-hydroxy atorvastatin-d5 lactone, and 4-hydroxy atorvastatin bisodium; and (b) an oil comprising an omega-3 fatty acid which comprises ethyl eicosapentaenoate and ethyl docosahexaenoate.
Patent NZ-602145-A (NZ)
Title: Ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis and/or urination disorders
Inventor: TAMAKI MAKOTO
IPC: A61K39/00
Filed: 2011-03-10
Abstract: Disclosed is the use of an extract from inflamed tissues inoculated with vaccinia virus as an active ingredient for the preparation of an ameliorating or therapeutic agent for chronic prostatitis, interstitial cystitis or urination disorder.
Patent NZ-603335-A (NZ)
Title: A sacrificial anode
Inventor: LAMBOURNE ALEXIS
IPC: C23F13/16
Filed: 2012-10-31
Abstract: 603335 Disclosed is a sacrificial anode to provide cathodic corrosion protection to a metallic body while maintaining the flow characteristics of a constrained fluid flow, particularly .within a water jet propulsion unit. The metallic body comprises a sacrificial anode located within a recess or cavity of the metallic body, where the recess has an opening with a curved edge profile to encourage fluid flow through the recess in normal use, the opening having a first dimension, wherein the sacrificial anode extends across up to 90% of the first dimension. . The sacrificial anode comprises a first layer of a first material; and a second layer of a second material which is located proximate to the first layer so that both layers are electrically connected of directly bonded together, wherein the first material is more anodic with respect to a galvanic series than the second material. The sacrificial anode is separated from the body by a channel that substantially surrounds the anode and electrically connected thereto, wherein the body is more cathodic with respect to a galvanic series than the first and second materials. The recess is located in a fluid washed surface of the body and a surface of the first material is located in the same plane as the fluid washed surface. The first material is magnesium and the second material is zinc.
Patent NZ-609198-A (NZ)
Title: Her2 dna vaccine as adjunct treatment for cancers in companion animals
Inventor: FISCHER LAURENT BERNARD
IPC: A61K39/00
Filed: 2011-10-13
Abstract: Disclosed is a method for treating canine mammary carcinoma/tumor in a dog suffering from a canine mammary carcinoma/tumor comprising: a) surgically debulking the tumor; and b) administering to the dog a clinically-effective amount of a xenogeneic differentiation antigen of the same type as a differentiation antigen expressed by mammary cells of the dog; and wherein canines receiving the antigen exhibit significantly increased overall, disease-free, and/or metastasis-free survival times relative to canines receiving the surgical debulking without subsequent immunization, thereby treating the carcinoma/tumor.
Patent NZ-610378-A (NZ)
Title: Lipoyl compounds and their use for treating ischemic injury
Inventor: BAGUISI ALEXANDER B
IPC: C07K5/06
Filed: 2011-11-10
Abstract: The disclosure relates to a family of compounds as shown in Formula (I), wherein X can either be absent of an amino acid and R and R’ are as disclosed in the specification. The disclosure also relates to a method of using these lipoyl compounds in the treatment of ischemic injury or ischemia-reperfusion injury. Examples of these compounds include: N-(R)-lipoyl-L-glutamyl-L-alanine N-(R)-lipoyl-3-aminobenzenesulfonic acid N-(R)-lipoyl-aminoethylphosponic acid N-(R)-lipoyliminodiacetic acid N-(R)-lipoyl-L-4-carboxyphenylalanine
Patent NZ-611871-A (NZ)
Title: Resource crew management
Inventor: DARRIN JOHN GRAFTON
IPC: G06Q50/14
Filed: 2012-06-14
Abstract: A method and a travel booking system for booking travel for a number of individuals for a corporate body are disclosed. The system comprises an information storage system storing details of the corporate body travel rules, access to a travel booking provider, a bulk file parser reading a bulk file provided by the corporate body, a travel booker booking individually the travel of each of the number of individuals to the destination in compliance with the corporate body travel rules and an email issuer issuing emails to individuals successfully booked. The bulk file includes details of the required destination of the number of individuals and details of the individuals sufficient to create a booking.
Patent NZ-617020-A (NZ)
Title: Improved trailer brake control system
Inventor: SIMPKIN RHYS DAVID
IPC: B62D63/08
Filed: 2012-10-25
Abstract: 617020 Disclosed is a wireless trailer brake control system (10) for communicating braking information between a tow vehicle and a trailer using wireless communication. The control system (10) is comprised of a tow vehicle controller (100) and a trailer sensing unit (200). The tow vehicle controller (100) includes a wireless transceiver and a multi-volt converter (120) for receiving power at multiple voltage levels. The trailer sensor unit (200) includes a trailer control module. The control module is comprised of a wireless transceiver, a multi-volt converter, an accelerometer and a microprocessor programmed to process information received from the tow vehicle controller (100) and the accelerometer. The trailer control module (200) is communicatively coupled to the trailer brake system (270) of the trailer.
Patent NZ-618857-A (NZ)
Title: Ceramic particle mixture, and method for manufacturing ceramic parts from such a mixture
Inventor: PETIT FABRICE
IPC: C04B35/622
Filed: 2012-05-31
Abstract: Disclosed is a method for manufacturing ceramic parts comprising: implementation of a ceramic particle mixture, as components, a predominant portion by weight of sinterable particles made of a ceramic material and an additive being a solid inorganic material (e.g., carbon based material such as graphite), wherein said inorganic solid material is absorbent for laser radiation emitting a predetermined energy flow at a predetermined wavelength, and at this wavelength has a specific absorptivity greater than that of the other components of the ceramic mixture, in that said ceramic mixture contains the particles of absorbent inorganic solid matter in the dispersed state, in proportions of less than 5 % by weight and more than 0 % by weight of the dry mixture, and in that the method further comprises; green shaping of this ceramic mixture and obtaining a dry green ceramic blank; green machining of the green ceramic blank, by removal of ceramic material by its exposure to said pulsed laser radiation emitting a predetermined energy flow at said predetermined wavelength, and; during said exposure to this laser radiation, direct selective absorption of the laser radiation energy by the particles of absorbent dispersed inorganic solid material which degrade abruptly, with gaseous emission, local dislocation of ceramic material from the green ceramic blank, ejection of this dislocated ceramic material and obtaining a machined ceramic part in the green state.
Patent NZ-710059-A (NZ)
Title: Nonlinear system identification for optimization of wireless power transfer
Inventor: HUNTER IAN W
IPC: H02J50/90
Filed: 2013-12-16
Abstract: Provided for is a method of detecting whether a receiver coil is near a transmit coil in a wireless power transfer system (WPTS) and satisfies a need to confirm that the detected receiver is located in the correct position. The method involves: applying a pseudo-random signal to the transmit coil; while the pseudo-random signal is being applied to the transmit coil, recording one or more signals produced within the WPTS in response to the applied pseudo-random signal; by using the one or more recorded signals, generating a dynamic system model for some aspect of the WPTS; and using the generated dynamic system model in combination with stored training data to determine whether an object having characteristics distinguishing the object as a receiver coil is near the transmit coil.
Patent NZ-715007-A (NZ)
Title: Nucleic acid molecules that target the vacuolar atpase c subunit and confer resistance to coleopteran pests
Inventor: NARVA KENNETH E
IPC: C12N15/82
Filed: 2011-12-30
Abstract: Disclosed is an isolated nucleic acid molecule comprising at least one polynucleotide(s) selected from the group consisting of: - a polynucleotide having at least 24 contiguous nucleotides of a native coding sequence of a Diabrotica organism comprising at least 24 contiguous nucleotides of SEQ ID NO:5; and - the complement of a polynucleotide having at least 24 contiguous nucleotides of a native coding sequence of a Diabrotica organism, comprising at least 24 contiguous nucleotides of SEQ ID NO:5, wherein the polynucleotide encodes an RNA molecule that functions upon contact with a coleopteran pest to inhibit the expression of a target polynucleotide within the coleopteran pest, and wherein the sequences is as defined in the complete specification.
Patent NZ-739902-A (NZ)
Title: Multiligand agent for drug delivery
Inventor: PAYNE JOSEPH
IPC: A61K47/54
Filed: 2016-07-29
Abstract: Described herein is a compound having the structure of formula I, II, or III, wherein R comprises a double stranded RNA molecule, and L1L2,and L3independently for each occurrence comprise a ligand selected from the group consisting of a carbohydrate, a cholesteryl, or a peptide; a pharmaceutically accepted salt or pharmaceutical composition thereof; and a method of making the compound.
Patent NZ-761006-A (NZ)
Title: Plasma kallikrein binding proteins and uses thereof in treating hereditary angioedema
Inventor: SEXTON DANIEL
IPC: G01N33/53
Filed: 2015-01-21
Abstract: Provided herein are plasma kallikrein binding proteins such as antibody DX-2930 (SEQ ID NO: 5-10) at a dose of 150mg every 2-4 weeks resulting the plasma concentration of the antibody in the subject to be above about 80 nM that binds to active plasma kallikrein and methods of using such proteins in treating hereditary angioedema.
Patent NZ-761625-A (NZ)
Title: Alcoholic beverage and method of making the same
Inventor: HALL DOUGLAS
IPC: C12G3/07
Filed: 2016-10-17
Abstract: The present invention is an alcoholic beverage having the sensory characteristics of a traditionally aged distilled spirit. The method for making the alcoholic beverage includes processing a specific ratio of wood chips to a volume of distilled spirit while under pressure by heating of the container alone, without the introduction of pressurised gas. The spirit having an ABV of 40% to 57%, the ratio of wood to spirit being 10-120g per 750ml and the pressure from 10 to 25 psi. This creates an accelerated interaction between the wood chips and distilled spirit to product a product with the sensory characteristics of a traditionally aged distilled spirit.